Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells
- 1 February 1998
- journal article
- Published by Elsevier in Research in Immunology
- Vol. 149 (2) , 139-150
- https://doi.org/10.1016/s0923-2494(98)80297-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxideInternational Journal of Immunopharmacology, 1995
- The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice.The Journal of Experimental Medicine, 1994
- Nitric Oxide-Releasing Agents Enhance Cytokine-Induced Tumor Necrosis Factor Synthesis in Human Mononuclear CellsBiochemical and Biophysical Research Communications, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse MacrophagesScience, 1992
- Effects of SIN-1 on Cytokine Synthesis in Human Mononuclear CellsJournal of Cardiovascular Pharmacology, 1991
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.Journal of Clinical Investigation, 1988
- Assay of a ribonuclease that preferentially hydrolyses mRNAs containing cytokine-derived UA-rich instability sequencesBiochemical and Biophysical Research Communications, 1988